Spots Global Cancer Trial Database for clarithromycin
Every month we try and update this database with for clarithromycin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study of Decadron, Biaxin, and Pomalidomide in Relapsed/Refractory Myeloma | NCT01159574 | Multiple Myelom... | dexamethasone clarithromycin Pomalidomide | 18 Years - | Weill Medical College of Cornell University | |
| A Trial With Metronomic Low-dose Treosulfan, Pioglitazone and Clarithromycin Versus Standard Treatment in NSCLC | NCT02852083 | Squamous Cell L... Non-Squamous Ce... Non-Small Cell ... | Pioglitazone nivolumab Treosulfan Clarithromycin | 18 Years - | University Hospital Regensburg | |
| Helicobacter - Lymphoma - Radiation Part I: Eradication, Part II: Radiation | NCT00154440 | Lymphoma Lymphoma, Non-H... | proton pump inh... clarithromycin amoxicillin metronidazole radiation thera... | 18 Years - 75 Years | Technische Universität Dresden | |
| Interaction Study of Zanubrutinib With Moderate and Strong CYP3A Inhibitors in Participants With B-Cell Malignancies | NCT04551963 | B-cell Malignan... | Zanubrutinib Fluconazole Diltiazem Voriconazole Clarithromycin | 18 Years - | BeiGene | |
| Chemoprevention Therapy in Treating Patients at High Risk of Developing Multiple Myeloma | NCT00006219 | Multiple Myelom... | clarithromycin prasterone | 18 Years - | Mayo Clinic | |
| A Study of LY2835219 in Participants With Cancer | NCT02117648 | Neoplasm Neoplasm Metast... | Abemaciclib Clarithromycin | 18 Years - | Eli Lilly and Company | |
| Clarithromycin in Multiple Myeloma Induction Therapy | NCT02573935 | Multiple Myelom... | Clarithromycin Placebo VCD induction t... | 18 Years - | Aalborg University Hospital | |
| Carfilzomib, Clarithromycin (Biaxin®), Lenalidomide (Revlimid®), and Dexamethasone (Decadron®) [Car-BiRD] Therapy for Subjects With Multiple Myeloma | NCT01559935 | Multiple Myelom... | carfilzomib Dexamethasone Clarithromycin Lenalidomide Dexamethasone Lenalidomide | 18 Years - | Weill Medical College of Cornell University | |
| Helicobacter - Lymphoma - Radiation Part I: Eradication, Part II: Radiation | NCT00154440 | Lymphoma Lymphoma, Non-H... | proton pump inh... clarithromycin amoxicillin metronidazole radiation thera... | 18 Years - 75 Years | Technische Universität Dresden | |
| Pharmacokinetics Study of Oral IXAZOMIB in Participants With Advanced Nonhematologic Malignancies or Lymphoma | NCT01454076 | Nonhematologic ... Lymphoma | Ixazomib 2.5 mg Ixazomib 4 mg C... Ixazomib 4 mg C... Ketoconazole Rifampin Clarithromycin Ixazomib 4 mg C... | 18 Years - | Takeda | |
| Helicobacter - Lymphoma - Radiation Part I: Eradication, Part II: Radiation | NCT00154440 | Lymphoma Lymphoma, Non-H... | proton pump inh... clarithromycin amoxicillin metronidazole radiation thera... | 18 Years - 75 Years | Technische Universität Dresden | |
| Effects of High-dose Dual Therapy and Bismuth Quadruple Therapy for Helicobacter Pylori Eradication on Intestinal Microecology | NCT05742568 | Gastritis Dyspepsia Helicobacter Py... Gastric Cancer Peptic Ulcer | Esomeprazole Amoxicillin Bismuth Esomeprazole Amoxicillin Clarithromycin | 18 Years - 70 Years | Xijing Hospital of Digestive Diseases | |
| Treatment of Selinexor in Combination With Clarithromycin, Pomalidomide and Dexamethasone for Relapsed Refractory Multiple Myeloma Patients | NCT04843579 | Myeloma Multipl... Myeloma Refractory Mult... | Selinexor Clarithromycin Pomalidomide Dexamethasone | 18 Years - 74 Years | Weill Medical College of Cornell University | |
| Is Clarithromycin a Potential Treatment for Cachexia in People With Lung Cancer? | NCT02416570 | Cachexia Lung Cancer | Clarithromycin Placebo | 18 Years - | University of Nottingham | |
| Carfilzomib, Clarithromycin (Biaxin®), Lenalidomide (Revlimid®), and Dexamethasone (Decadron®) [Car-BiRD] Therapy for Subjects With Multiple Myeloma | NCT01559935 | Multiple Myelom... | carfilzomib Dexamethasone Clarithromycin Lenalidomide Dexamethasone Lenalidomide | 18 Years - | Weill Medical College of Cornell University | |
| Treatment of Selinexor in Combination With Clarithromycin, Pomalidomide and Dexamethasone for Relapsed Refractory Multiple Myeloma Patients | NCT04843579 | Myeloma Multipl... Myeloma Refractory Mult... | Selinexor Clarithromycin Pomalidomide Dexamethasone | 18 Years - 74 Years | Weill Medical College of Cornell University | |
| Antibiotic Therapy and Antacids in Patients With Malt Lymphoma of the Stomach | NCT00002682 | Lymphoma | Amoxicillin Bismuth Subsali... Clarithromycin Metronidazole H... Omeprazole Tetracycline Hy... | 18 Years - 80 Years | M.D. Anderson Cancer Center | |
| Chlorambucil Compared With No Further Therapy Following Anti-Helicobacter Therapy in Treating Patients With Low-Grade Lymphoma of the Stomach | NCT00003617 | Gastric Cancer | chlorambucil clarithromycin omeprazole tinidazole | 16 Years - | National Cancer Institute (NCI) | |
| Lenalidomide, Dexamethasone, and Clarithromycin in Treating Patients Who Have Undergone Stem Cell Transplant for Multiple Myeloma | NCT00445692 | DS Stage I Plas... DS Stage II Pla... DS Stage III Pl... Refractory Plas... | Clarithromycin Dexamethasone Lenalidomide | 18 Years - | Fred Hutchinson Cancer Center | |
| Ixazomib With Pomalidomide, Clarithromycin and Dexamethasone in Treating Patients With Multiple Myeloma | NCT02542657 | Myeloma | Clarithromycin Dexamethasone Ixazomib Citrat... Pomalidomide | 18 Years - | University of California, Davis | |
| Interaction Study of Zanubrutinib With Moderate and Strong CYP3A Inhibitors in Participants With B-Cell Malignancies | NCT04551963 | B-cell Malignan... | Zanubrutinib Fluconazole Diltiazem Voriconazole Clarithromycin | 18 Years - | BeiGene | |
| Feasibility Study of the Proposed Test-and-treat Screening Program in Younger Participants With H. Pylori Infection | NCT06216639 | Helicobacter Py... | Bismuth Subcitr... Esomeprazole Metronidazole Amoxicillin Clarithromycin Levofloxacin | 30 Years - 34 Years | National Institute of Public Health, Slovenia | |
| Is Clarithromycin a Potential Treatment for Cachexia in People With Lung Cancer? | NCT02416570 | Cachexia Lung Cancer | Clarithromycin Placebo | 18 Years - | University of Nottingham | |
| Autologous Stem Cell Transplant With Pomalidomide (CC-4047®) Maintenance Versus Continuous Clarithromycin/ Pomalidomide / Dexamethasone Salvage Therapy in Relapsed or Refractory Multiple Myeloma | NCT01745588 | Multiple Myelom... | Pomalidomide stem cell Dexamethasone Clarithromycin | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Cohorts of Docetaxel or Cabazitaxel in Combination With the Potent CYP3A4 Inhibitor, Clarithromycin | NCT03043989 | Prostate Cancer | Docetaxel Cabazitaxel Clarithromycin | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Macrolides for KCNJ5 - Mutated Aldosterone-Producing Adenoma (MAPA) | NCT03414918 | Hyperaldosteron... | Clarithromycin | 18 Years - 75 Years | University Hospital Padova | |
| Lenalidomide, Dexamethasone, and Clarithromycin in Treating Patients Who Have Undergone Stem Cell Transplant for Multiple Myeloma | NCT00445692 | DS Stage I Plas... DS Stage II Pla... DS Stage III Pl... Refractory Plas... | Clarithromycin Dexamethasone Lenalidomide | 18 Years - | Fred Hutchinson Cancer Center | |
| Clarithromycin in Multiple Myeloma Induction Therapy | NCT02573935 | Multiple Myelom... | Clarithromycin Placebo VCD induction t... | 18 Years - | Aalborg University Hospital | |
| Feasibility Study of the Proposed Test-and-treat Screening Program in Younger Participants With H. Pylori Infection | NCT06216639 | Helicobacter Py... | Bismuth Subcitr... Esomeprazole Metronidazole Amoxicillin Clarithromycin Levofloxacin | 30 Years - 34 Years | National Institute of Public Health, Slovenia | |
| A Phase II Study of Daratumumab, Clarithromycin, Pomalidomide And Dexamethasone (D-ClaPd) In Multiple Myeloma Patients Previously Exposed to Daratumumab | NCT04302324 | Multiple Myelom... Refractory Mult... Relapse Multipl... | Daratumumab SC Clarithromycin Pomalidomide Dexamethasone | 18 Years - 75 Years | Weill Medical College of Cornell University | |
| Antibiotic Therapy in Treating Patients With Low Grade Gastric Lymphoma | NCT00003151 | Lymphoma | bismuth subcitr... amoxicillin clarithromycin metronidazole h... omeprazole tetracycline hy... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| A Trial With Metronomic Low-dose Treosulfan, Pioglitazone and Clarithromycin Versus Standard Treatment in NSCLC | NCT02852083 | Squamous Cell L... Non-Squamous Ce... Non-Small Cell ... | Pioglitazone nivolumab Treosulfan Clarithromycin | 18 Years - | University Hospital Regensburg | |
| GEM-CLARIDEX: Ld vs BiRd | NCT02575144 | Multiple Myelom... | Clarithromycin Lenalidomide Dexamethasone | 18 Years - | PETHEMA Foundation | |
| Cohorts of Docetaxel or Cabazitaxel in Combination With the Potent CYP3A4 Inhibitor, Clarithromycin | NCT03043989 | Prostate Cancer | Docetaxel Cabazitaxel Clarithromycin | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Clarithromycin Plus CTd Regimen for Patients With Newly Diagnosed Multiple Myeloma | NCT02248428 | Multiple Myelom... | Clarithromycin Thalidomide Cyclophosphamid... Dexamethasone | 18 Years - | Jinling Hospital, China | |
| GEM-CLARIDEX: Ld vs BiRd | NCT02575144 | Multiple Myelom... | Clarithromycin Lenalidomide Dexamethasone | 18 Years - | PETHEMA Foundation | |
| Antibiotic Therapy in Treating Patients With Low Grade Gastric Lymphoma | NCT00003151 | Lymphoma | bismuth subcitr... amoxicillin clarithromycin metronidazole h... omeprazole tetracycline hy... | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
